Acne Treatment's Oil-Reducing power put to the test
NCT ID NCT06415279
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates whether clascoterone cream 1%, an FDA-approved acne medication, works by reducing sebum (skin oil) production. Researchers will measure forehead oil levels and changes in skin bacteria in 40 participants aged 12 and older with mild to moderate acne. The goal is to confirm the cream's mechanism of action and its effect on the skin microbiome over 12 and 52 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
clascoterone cream 1%
What this could lead to
If successful, this study could confirm that clascoterone cream works by reducing sebum, supporting its use as a targeted acne treatment.
What could go wrong
This is a small, early-phase trial with only 40 participants, so results may not apply to everyone. The sebum reduction may not translate to better acne clearance in all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACNE VULGARIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dermatology Consulting Services, PLLC
High Point, North Carolina, 27262, United States